Medanta Analyst Rating
based on 14 analysts
38.46%
Buy
38.46%
Hold
23.08%
Sell
Based on 14 analysts offering long term price targets for Medanta. An average target of ₹1191.14
Source: S&P Global Market Intelligence
Medanta Share analysis
Medanta price forecast by 14 analysts
Upside of16.69%
High
₹1440
Target
₹1191.14
Low
₹855
Medanta target price ₹1191.14, a slight upside of 16.69% compared to current price of ₹1020.75. According to 14 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Medanta revenue growth forecast
Expected growth rate Q1, FY2027:82.97%
Forecast
Actual
Including amortisation and stock based compensations
Medanta EPS growth forecast
EPS estimate Q1, FY2027:136.27%
Forecast
Actual
Source: S&P Global Market Intelligence
Medanta Performance
Day's Low
Day's High
₹1,016.95Day's Price Range₹1,029.0552 Week's Low
52 Week's High
₹935.552-Week Price Range₹1,513.9
| Returns % | |
| 1 Month Return | -10 % |
| 3 Month Return | -4.4 % |
| 1 Year Return | -3.82 % |
| Market Stats | |
| Previous Close | ₹1,027.05 |
| Open | ₹1,027.05 |
| Volume | 2.22L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹27,585.27Cr |
Medanta Key Statistics
| P/E Ratio | 56.15 |
| PEG Ratio | 19.56 |
| Market Cap | ₹27,585.27 Cr |
| P/B Ratio | 12.48 |
| EPS | 12.16 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 13.52 |
Medanta Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹27,585.27 Cr | 29.16% | 0.55 | ₹326 Cr | ₹2,694 Cr | |
| BUY | ₹1,451.47 Cr | -2.08% | 0.59 | ₹41 Cr | ₹337 Cr | |
| NA | ₹281.01 Cr | -0.24% | 0.50 | NA | NA | |
| NA | ₹192.44 Cr | -1.51% | 0.71 | ₹4 Cr | ₹84 Cr | |
| NA | ₹36.80 Cr | 0.28% | 0.64 | NA | NA |
Medanta Mutual Fund Holdings
About Medanta
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Share Price: ₹1020.75 per share as on 17 Jan, 2025 04:01 PM
Market Capitalisation: ₹27,585.27Cr as of today
Revenue: ₹956.56Cr as on September 2024 (Q3 24)
Net Profit: ₹130.82Cr as on September 2024 (Q3 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Medanta |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Global Health Ltd
Emkay Initiates Coverage on Global Health with Caution - 16 Jan, 2025
Emkay has initiated coverage on Global Health Ltd (Medanta) with a 'reduce' rating and a price target of ₹1,000, indicating caution. The firm awaits better entry points as the company navigates delayed project timelines and increasing competition in new markets.Healthcare Theme Expected to Thrive Amid Resilience - 08 Jan, 2025
The healthcare sector, particularly Global Health Ltd (Medanta), is anticipated to perform well due to earnings resilience, improved realizations, and plans to double bed capacity. Valuations remain attractive compared to peers.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 836.05 Cr → 974.77 Cr (in ₹), with an average increase of 7.4% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 9.03% to 9.59% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 106.29 Cr → 130.84 Cr (in ₹), with an average increase of 18.8% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 43.44% to 43.65% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 60.0% return, outperforming this stock by 57.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.04% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 12.94% to 12.20% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, MEDANTA stock has moved down by -3.4%
Medanta Financials
Index Inclusions
Medanta Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 33.04% | ||
| Foreign Institutions | 12.2% | ||
| Mutual Funds | 9.59% | 6.15 | |
| Retail Investors | 43.65% | 0.47 | |
| Others | 1.52% |
Medanta Key Indicators
Medanta Valuation
Medanta in the last 5 years
Lowest (37.92x)
April 6, 2023
Today (56.15x)
January 17, 2025
Industry (97.73x)
January 17, 2025
Highest (88.30x)
February 23, 2024
Medanta Earnings and Dividends
Global Health Ltd Earnings Results
Global Health Ltd’s net profit jumped 4.54% since last year same period to ₹130.84Cr in the Q2 2024-2025. On a quarterly growth basis, Global Health Ltd has generated 23.1% jump in its net profits since last 3-months.
Read More about Earnings Results
Medanta Technicals Summary
Bearish
Neutral
Bullish
Global Health Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Global Health Ltd
Global Health Ltd share price today stands at ₹1020.75, Open. ₹1027.05 ; Previous Close. ₹1027.05 ; High. ₹1029.05 ; Low. ₹1016.95 ; 52 Week High. ₹1513.9 ; 52 Week Low: ₹935.5.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Global Health Ltd shares.
Global Health Ltd is listed on NSE
Global Health Ltd is listed on BSE
- Today’s highest price of Global Health Ltd is ₹1029.05.
- Today’s lowest price of Global Health Ltd is ₹1016.95.
PE Ratio of Global Health Ltd is 56.15
PE ratio = Global Health Ltd Market price per share / Global Health Ltd Earnings per share
Today’s traded volume of Global Health Ltd(MEDANTA) is 2.22L.
Today’s market capitalisation of Global Health Ltd(MEDANTA) is ₹27585.27Cr.
| Global Health Ltd(MEDANTA | Price |
|---|---|
52 Week High | ₹1513.9 |
52 Week Low | ₹935.5 |
Global Health Ltd(MEDANTA) share price is ₹1020.75. It is down -32.57% from its 52 Week High price of ₹1513.9
Global Health Ltd(MEDANTA) share price is ₹1020.75. It is up 9.11% from its 52 Week Low price of ₹935.5
| Global Health Ltd(MEDANTA | Returns |
|---|---|
1 Day Returns | -6.3% |
1 Month Returns | -10% |
3 Month Returns | -4.4% |
1 Year Returns | -3.82% |